Study Says Stop Taking Medication To Avoid Further Bisphosphonate Side Effects If You Suffered A Fosamax Thigh
On February 8, 2012, research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (“AAOS”) concluded that patients who suffer a Fosamax thigh fracture while taking bisphosphonates such as Fosamax, Boniva, Reclast and Actonel can decrease their risk of suffering from future bisphosphonate side effects by discontinuing use of the medication. Bisphosphonates, such as Fosamax, are used to treat osteoporosis, osteopenia, and to help prevent bone loss. Over five million people take bisphosphonates annually. However, studies have shown that bisphosphonate side effects are dangerous and can be life-threatening. For example, a Fosamax thigh fracture is one of the more serious bisphosphonate side effects. A Fosamax thigh fracture is a sudden break of the femur, which can occur with little or no trauma at all. In conducting the study on bisphosphonate side effects, researchers examined records of 126 patients over a three year period who sustained a Fosamax thigh fracture while taking Fosamax or a similar medication. Of those patients, 41.2% who continued taking the drugs after the initial break, suffered a second fracture in the other thigh three or more years later. In contrast, only 19.3% of those who stopped taking bisphosphonates suffered a second break. Thus, a patient can greatly reduce her risk of suffering from long-term bisphosphonate side effects by stopping the medication after an initial break. Researchers concluded that the chance of sustaining a subsequent Fosamax thigh fracture dropped by 53% when patients stopped taking bisphosphonates after the first fracture. Dr. Richard Dell, who led the study on bisphosphonate side effects said, “Based on these observations, we recommend discontinuing bisphosphonate use as soon as possible after the initial atypical femur fracture has occurred.”
Merck Defending Fosamax Thigh Fracture Lawsuits Nationwide
Fosamax, manufactured by Merck, was approved by the U.S. Food and Drug Administration in 1995. Before it became available in generic form, Fosamax sales topped $3 billion annually. It is the mostly widely prescribed bisphosphonate in the United States. However, given the severe bisphosphonate side effects associated with Fosamax and similar medications, many individuals who sustained a Fosamax thigh fracture as a result of taking the medication have filed lawsuits against Merck seeking compensation for their injuries. Currently, Merck is defending Fosamax lawsuits nationwide, filed by individuals who sustained a Fosamax femur fracture.
Fosamax Lawsuits Stem From Serious Bisphosphonate Side Effects
Because bisphosphonate side effects can cause a variety of severe, potentially permanent health problems, including a Fosamax thigh fracture, many afflicted patients have sought compensation by filing individual Fosamax lawsuits. The lawyers at Bernstein Liebhard LLP are actively filing lawsuits on behalf of those who sustained a femur fracture, one of the severe side effects of Fosamax. If you suffered a Fosamax thigh fracture, our team of Fosamax lawyers can help you seek compensation for your injuries.
If you took Fosamax and believe bisphosphonate side effects caused your injury, contact us today to learn more about your legal options.